Avid Bioservices Net Income
| CDMODelisted Stock | USD 12.49 0.00 0.00% |
As of the 16th of February 2026, Avid Bioservices shows the Risk Adjusted Performance of 0.1652, mean deviation of 0.6752, and Coefficient Of Variation of 503.88. Avid Bioservices technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Avid Bioservices' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Avid Bioservices' valuation are provided below:Avid Bioservices does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Avid |
Search Suggestions
| CD | Chaince Digital Holdings | Company |
| CDZIP | Cadiz Depositary Shares | Company |
| CDAZX | Multi Manager Directional Alternative | Mutual Fund |
| CDC | VictoryShares EQ Income | ETF |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Avid Bioservices reported net income of (140.75 Million). This is 141.24% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 124.65% higher than that of the company.
Avid Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avid Bioservices' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avid Bioservices could also be used in its relative valuation, which is a method of valuing Avid Bioservices by comparing valuation metrics of similar companies.Avid Bioservices is currently under evaluation in net income category among its peers.
Avid Fundamentals
| Return On Equity | -1.16 | |||
| Return On Asset | -0.0305 | |||
| Profit Margin | (1.01) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 971.01 M | |||
| Shares Outstanding | 63.96 M | |||
| Shares Owned By Insiders | 1.13 % | |||
| Shares Owned By Institutions | 98.87 % | |||
| Number Of Shares Shorted | 11.62 M | |||
| Price To Earning | 10.76 X | |||
| Price To Book | 17.83 X | |||
| Price To Sales | 5.61 X | |||
| Revenue | 139.91 M | |||
| Gross Profit | 8.93 M | |||
| EBITDA | (11.48 M) | |||
| Net Income | (140.75 M) | |||
| Cash And Equivalents | 115.14 M | |||
| Cash Per Share | 1.85 X | |||
| Total Debt | 207.83 M | |||
| Debt To Equity | 1.02 % | |||
| Current Ratio | 1.93 X | |||
| Book Value Per Share | 0.96 X | |||
| Cash Flow From Operations | 10.95 M | |||
| Short Ratio | 3.19 X | |||
| Earnings Per Share | (2.41) X | |||
| Price To Earnings To Growth | 16.30 X | |||
| Target Price | 12.5 | |||
| Number Of Employees | 371 | |||
| Beta | 1.41 | |||
| Market Capitalization | 798.9 M | |||
| Total Asset | 336.56 M | |||
| Retained Earnings | (571.87 M) | |||
| Working Capital | 33.44 M | |||
| Current Asset | 25.65 M | |||
| Current Liabilities | 10.9 M | |||
| Net Asset | 336.56 M |
About Avid Bioservices Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avid Bioservices's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avid Bioservices using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avid Bioservices based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Avid Stock
If you are still planning to invest in Avid Bioservices check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Avid Bioservices' history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |